Xylohexaose
CAS No. 49694-21-5
Xylohexaose( ——— )
Catalog No. M38983 CAS No. 49694-21-5
Xylohexaose is a xylooligosaccharide consisting of six xylose residues. Xylohexaose can be used as substrate in the xylan hydrolysis properties assay.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 307 | In Stock |
|
| 10MG | 455 | In Stock |
|
| 25MG | 746 | In Stock |
|
| 50MG | 1004 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXylohexaose
-
NoteResearch use only, not for human use.
-
Brief DescriptionXylohexaose is a xylooligosaccharide consisting of six xylose residues. Xylohexaose can be used as substrate in the xylan hydrolysis properties assay.
-
DescriptionXylohexaose is a hexasaccharide consisting of six xylose residues.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number49694-21-5
-
Formula Weight810.705
-
Molecular FormulaC30H50O25
-
Purity>98% (HPLC)
-
SolubilityH2O : 400 mg/mL (493.40 mM; ultraphonic)
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Ponasterone A
Ponasterone A is an analog of 20-hydroxy ecdysone.
-
Desoxo-narchinol A
Desoxo-narchinol A exhibits protective effects against LPS-induced endotoxin shock and inflammation through p38 deactivation, it shows inhibitory activity against LPS-induced NO production. Desoxo-narchinol A shows cytotoxic activity against P-388 cells.
-
Neuropeptide SF (hum...
Neuropeptide SF human augments paraventricular corticotrophin-releasing hormone (CRH) release and increases adrenocorticotropic hormone (ACTH) and corticosterone levels in the plasma. Neuropeptide SF human play a physiologic role in the regulation of such circadian functions as the activity of motor centers and the HPA axis, through the release of CRH.
Cart
sales@molnova.com